Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06415630
Other study ID # WHUH-AADreintu
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2018
Est. completion date December 31, 2023

Study information

Verified date May 2024
Source Wuhan Union Hospital, China
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Reintubation is an adverse postoperative complication in patients with Type A aortic dissection (AAD) that correlates to poor outcomes. This study aims to analyze the risk factors associated with reintubation and to create a fully automated score model to predict the incidence of reintubation. A total of 861 patients diagnosed with AAD and undergoing surgical procedures in a single institution between January 2018 and October 2023 were selected in wuhan Union Hospital. Preoperative and postoperative informmation was used for seeking risk factors and build prediction model for postoperative reintubation. Finally, 5 risk factors wasidentified and a nomogram was established for predicting postoperative reintubation in patients with AAD.


Recruitment information / eligibility

Status Completed
Enrollment 861
Est. completion date December 31, 2023
Est. primary completion date October 31, 2023
Accepts healthy volunteers
Gender All
Age group 19 Years to 90 Years
Eligibility Inclusion Criteria: (1) patients diagnosed with AAD admitted for open surgery; (2) aged 18 years or older. Exclusion Criteria: (1) patients deceased during or within 24 hours after surgery; (2) patients with preoperative intubation.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Type A aortic dissection surgery
Patients with type A aortic dissection undergone surgery.

Locations

Country Name City State
China Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei

Sponsors (1)

Lead Sponsor Collaborator
Wuhan Union Hospital, China

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary postoperative reintubation reintubation incidence in patients with type A aortic dissection undergoing surgery 3 month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06199401 - Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery N/A
Active, not recruiting NCT03369977 - BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients N/A
Completed NCT05751200 - Safety and Efficacy of Aortic Root Reinforcement Combined With Vascular Grafts Eversion and built-in Procedure (XJ-procedure) in Patients With Acute Type A Aortic Dissection (ADVANCED-XJ )
Completed NCT04711889 - Additive Anti-inflammatory Action for Aortopathy & Arteriopathy (Ulinastatin) II N/A
Recruiting NCT03607786 - Antegrade Cerebral Perfusion and Retrograde Inferior Vena Caval Perfusion for Total Aortic Arch Replacement N/A
Enrolling by invitation NCT05927090 - Outcomes of Type A Aortic Dissection Repair
Completed NCT05346497 - Surgical Management of the Aortic Root and Long-term Outcomes For Acute Type A Aortic Dissection
Active, not recruiting NCT04831073 - European Registry of Type A Aortic Dissection
Recruiting NCT06434987 - Impact of RIVP on GI Function in Patients Undergoing Surgical Repair for ATAAD
Completed NCT02164201 - Post Market Surveillance Study Evaluating BioFoam Surgical Matrix in Cardiovascular Surgery N/A
Recruiting NCT04032366 - iNO as Salvage Treatment of Hypoxemia After TAAD Surgery